Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Budriesi

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Current Medicinal Chemistry|November 5, 2011
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRsP Ioan, E Carosati, M Micucci, et al.
Phytochemistry|December 7, 2019
Antihypertensive phytocomplexes of proven efficacy and well-established use: Mode of action and individual characterization of the active constituentsM Micucci, C Bolchi, R Budriesi, et al.
European Journal of Pharmacology|December 1, 1998
Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivativeR Budriesi, G Aicardi, G Campana, et al.
Journal of Medicinal Chemistry|November 16, 2001
Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activatorsC Melchiorre, M L Bolognesi, R Budriesi, et al.
Journal of Medicinal Chemistry|October 27, 1995
Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activityG Campiani, A Garofalo, I Fiorini, et al.
Journal of Medicinal Chemistry|May 29, 1999
Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar rangeE Teodori, S Dei, P Quidu, et al.
British Journal of Pharmacology|February 28, 2001
Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-aminesR Budriesi, S Cacciaguerra, R D Toro, et al.
Journal of Medicinal Chemistry|October 9, 1999
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptorsM L Bolognesi, R Budriesi, A Cavalli, et al.
Journal of Medicinal Chemistry|December 22, 1999
Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonistsM Rosini, R Budriesi, M G Bixel, et al.
Journal of Medicinal Chemistry|July 19, 1996
Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockersG Campiani, I Fiorini, M P De Filippis, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Current Medicinal Chemistry|November 5, 2011
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRsP Ioan, E Carosati, M Micucci, et al.
Phytochemistry|December 7, 2019
Antihypertensive phytocomplexes of proven efficacy and well-established use: Mode of action and individual characterization of the active constituentsM Micucci, C Bolchi, R Budriesi, et al.
European Journal of Pharmacology|December 1, 1998
Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivativeR Budriesi, G Aicardi, G Campana, et al.
Journal of Medicinal Chemistry|November 16, 2001
Design, synthesis, and biological activity of methoctramine-related polyamines as putative G(i) protein activatorsC Melchiorre, M L Bolognesi, R Budriesi, et al.
Journal of Medicinal Chemistry|October 27, 1995
Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activityG Campiani, A Garofalo, I Fiorini, et al.
Journal of Medicinal Chemistry|May 29, 1999
Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar rangeE Teodori, S Dei, P Quidu, et al.
British Journal of Pharmacology|February 28, 2001
Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-aminesR Budriesi, S Cacciaguerra, R D Toro, et al.
Journal of Medicinal Chemistry|October 9, 1999
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptorsM L Bolognesi, R Budriesi, A Cavalli, et al.
Journal of Medicinal Chemistry|December 22, 1999
Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonistsM Rosini, R Budriesi, M G Bixel, et al.
Journal of Medicinal Chemistry|July 19, 1996
Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockersG Campiani, I Fiorini, M P De Filippis, et al.
Pageof 4